[go: up one dir, main page]

MA53828A - Compositions et méthodes pour le traitement d'infections pathogènes dans des plantes - Google Patents

Compositions et méthodes pour le traitement d'infections pathogènes dans des plantes

Info

Publication number
MA53828A
MA53828A MA053828A MA53828A MA53828A MA 53828 A MA53828 A MA 53828A MA 053828 A MA053828 A MA 053828A MA 53828 A MA53828 A MA 53828A MA 53828 A MA53828 A MA 53828A
Authority
MA
Morocco
Prior art keywords
plants
compositions
methods
pathogenic infections
treating pathogenic
Prior art date
Application number
MA053828A
Other languages
English (en)
Inventor
Goutam Gupta
Eddie W Stover
Original Assignee
Innate Immunity LLC
Us Agriculture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innate Immunity LLC, Us Agriculture filed Critical Innate Immunity LLC
Publication of MA53828A publication Critical patent/MA53828A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H3/00—Processes for modifying phenotypes, e.g. symbiosis with bacteria
    • A01H3/04—Processes for modifying phenotypes, e.g. symbiosis with bacteria by treatment with chemicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8237—Externally regulated expression systems
    • C12N15/8239—Externally regulated expression systems pathogen inducible
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Environmental Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA053828A 2018-10-01 2019-10-01 Compositions et méthodes pour le traitement d'infections pathogènes dans des plantes MA53828A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16/148,848 US20200102356A1 (en) 2018-10-01 2018-10-01 Compositions and Methods for the Treatment of Huanglongbing (HLB) aka Citrus Greening in Citrus Plants

Publications (1)

Publication Number Publication Date
MA53828A true MA53828A (fr) 2022-01-05

Family

ID=69945419

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053828A MA53828A (fr) 2018-10-01 2019-10-01 Compositions et méthodes pour le traitement d'infections pathogènes dans des plantes

Country Status (8)

Country Link
US (1) US20200102356A1 (fr)
EP (1) EP3860619A4 (fr)
CN (1) CN113164513A (fr)
AU (1) AU2019351903A1 (fr)
BR (1) BR112021006310A2 (fr)
MA (1) MA53828A (fr)
MX (1) MX2021003849A (fr)
WO (1) WO2020072535A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112640711B (zh) * 2020-12-24 2022-09-20 深圳市硒惠农生物科技有限公司 一种防治柚子树黄龙病的方法
CN113402613B (zh) * 2021-01-19 2022-06-14 东北农业大学 抗菌肽ll37活性中心衍生肽二倍体抗菌肽lg及其制备方法和应用
EP4384199A4 (fr) * 2021-08-11 2025-07-02 The Regents Of Univ Of California Peptides pour membranes conservant une fonction barrière
CN114573672B (zh) * 2022-03-21 2022-10-04 中国农业科学院农业基因组研究所 西瓜苦味物质葫芦素e的转运蛋白及其应用
US20250243245A1 (en) * 2022-04-12 2025-07-31 DiverseVitality.com LLC d/b/a/ Diverse Vitality Antibacterial Chimeric Peptides and Their Methods of Therapeutic Use
CN116715733A (zh) * 2022-10-18 2023-09-08 深圳润康生态环境股份有限公司 一种有效抑制柑橘黄龙病病原菌增殖的抗菌肽stj-2及其应用
WO2024145551A1 (fr) 2022-12-29 2024-07-04 Biotalys NV Compositions agrochimiques
EP4642233A1 (fr) 2022-12-30 2025-11-05 Biotalys NV Agglomérat
WO2024141638A1 (fr) 2022-12-30 2024-07-04 Biotalys NV Concentré auto-émulsifiable
EP4642916A2 (fr) 2022-12-30 2025-11-05 Biotalys NV Signaux de sécrétion
EP4574981A1 (fr) 2023-12-22 2025-06-25 Biotalys NV Anticorps vhh antifongiques

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08511007A (ja) * 1993-06-09 1996-11-19 コノート ラボラトリーズ リミテッド タンデム合成ｈｉｖ−１ペプチド
US8212110B2 (en) * 2003-05-14 2012-07-03 Integrated Plant Genetics, Inc. Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria
US9181310B2 (en) * 2003-05-14 2015-11-10 University Of Florida Research Foundation, Inc. Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria
US7919601B2 (en) * 2003-05-14 2011-04-05 Integrated Plant Genetics, Inc. Identification and use of genes encoding holins and holin-like proteins in plants for the control of microbes and pests
WO2005019242A2 (fr) * 2003-08-18 2005-03-03 E.I. Dupont De Nemours And Company Expression de recombinaison du peptide hag1 anti-microbien: utilisation en tant que partenaire de fusion pour l'expression de peptides alpha helicoidaux antimicrobiens
MXPA06011242A (es) * 2004-03-29 2007-01-16 Univ Arizona Glicopeptidos anfipaticos.
WO2006044596A2 (fr) * 2004-10-15 2006-04-27 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Peptides helicoidaux amphipathiques a plusieurs domaines et leurs methodes d'utilisation
EP1848265A2 (fr) * 2005-01-26 2007-10-31 Washington State University Research Foundation Peptides signal pour la defense de plantes
JP2010505831A (ja) * 2006-10-05 2010-02-25 ニューヨーク ブラッド センター， インコーポレイテッド 安定化した、治療用の小型のヘリックス性抗ウイルスペプチド
EP2120983A4 (fr) * 2006-12-21 2010-10-13 Us Army Composés peptidomimétiques antimicrobiens et procédés d'évaluation d'activité antimicrobienne
WO2008083493A1 (fr) * 2007-01-10 2008-07-17 University Of Saskatchewan Stabilisation de structures de peptides cycliques
EP2118122B1 (fr) * 2007-01-16 2015-09-23 The Regents of The University of California Nouveaux peptides antimicrobiens
GB0821687D0 (en) * 2008-11-28 2008-12-31 Secr Defence Peptides
US8722616B2 (en) * 2009-10-22 2014-05-13 Board Of Regents Of The University Of Nebraska Anti-HIV peptides and methods of use thereof
EP3059242A4 (fr) * 2013-10-17 2017-04-19 Seoul National University R&DB Foundation Multimère de peptides de pénétration cellulaire à hélice alpha, procédé de préparation associé et utilisation associée
JP6613312B2 (ja) * 2014-10-14 2019-11-27 ジ ユナイテッド ステイツ オブ アメリカ アズ リプリゼンティッド バイ ザ セクレタリー，デパートメント オブ ヘルス アンド ヒューマン サービシズ 膵臓癌を処置するためのペプチドをベースとする方法
EP3903823A3 (fr) * 2015-03-23 2022-02-23 Riptide Bioscience, Inc. Peptides antimicrobiens et leurs procédés d'utilisation
US10611799B2 (en) * 2017-03-03 2020-04-07 National Tsing Hua University Anti-endotoxin polypeptide

Also Published As

Publication number Publication date
AU2019351903A1 (en) 2021-05-13
MX2021003849A (es) 2021-09-08
EP3860619A1 (fr) 2021-08-11
WO2020072535A1 (fr) 2020-04-09
US20200102356A1 (en) 2020-04-02
CN113164513A (zh) 2021-07-23
BR112021006310A2 (pt) 2021-08-31
EP3860619A4 (fr) 2022-10-26

Similar Documents

Publication Publication Date Title
MA53828A (fr) Compositions et méthodes pour le traitement d'infections pathogènes dans des plantes
EP3924481A4 (fr) Compositions et méthodes de traitement d'hémoglobinopathies
MA53558A (fr) Compositions et procédés pour le traitement d'infections virales
EP3490366A4 (fr) Procédés et compositions pour l'expression de gènes dans des plantes
MA51056A (fr) Compositions et méthodes pour le traitement d'affections métaboliques
EP3641746A4 (fr) Méthodes et compositions pour le traitement d'une infection microbienne
EP3458079A4 (fr) Compositions et méthodes pour le traitement de l'acné
EP3423100A4 (fr) Compositions destinées à traiter l'inflammation et méthodes de traitement associées
MA52861A (fr) Méthodes et compositions pour le traitement de l'apnée du sommeil
EP3512524A4 (fr) Méthodes et compositions de traitement d'infections virales
EP3668317A4 (fr) Inhibition photodynamique d'agents pathogènes microbiens dans des plantes
EP3405191A4 (fr) Méthodes et compositions pour le traitement de l'hyperhidrose
MA47504A (fr) Composés et méthodes de traitement de l'angiocholite biliaire primitive
MA49576A (fr) Compositions et méthodes pour le traitement d'infections fongiques
EP3810091A4 (fr) Méthodes et compositions pour le traitement de l'hypertension pulmonaire
EP3496743A4 (fr) Compositions et méthodes pour le traitement du cancer par déplétion en arginine et à l'aide d'agents d'immuno-oncologie
EP4114422A4 (fr) Compositions et méthodes pour le traitement d'infections bactériennes intracellulaires
EP3400008A4 (fr) Compositions thérapeutiques et méthodes pour le traitement de l'hépatite b
EP3368048A4 (fr) Méthodes et compositions pour le traitement de l'amyloïdose
EP3638270A4 (fr) Compositions et méthodes pour l'amélioration d'un traitement par hyperthermie
EP3595689A4 (fr) Méthodes et compositions pour traiter l'obésité, l'inflammation ou des troubles métaboliques avec des bactériophages
EP3877012A4 (fr) Méthodes et composition pour le traitement d'infections microbiennes
EP3654961A4 (fr) Méthodes et compositions pour le traitement de la douleur à l'aide de la capsaïcine
EP3773221A4 (fr) Traitement pour l'hydrocéphalie
EP3638287A4 (fr) Méthodes et compositions pour le traitement d'une inflammation microbienne